General Atlantic LLC Pharvaris N.V. Put Options Transaction History
General Atlantic LLC
- $2.96 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PHVS
# of Institutions
52Shares Held
39.2MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$89.6 Million78.82% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$87.2 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$74.2 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$67.1 Million17.41% of portfolio
-
Vr Adviser, LLC New York, NY3.11MShares$63.3 Million11.8% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $686M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...